@article{28e5cb60c2b9406eb7940e877e51e479,
title = "No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic",
abstract = "NA",
keywords = "Betacoronavirus, Biological Products, COVID-19, Coronavirus Infections, Humans, Immunosuppressive Agents, Italy, Pandemics, Pneumonia, Viral, Receptors, Interleukin-6, Respiration Disorders, Rheumatic Diseases, Risk Factors, SARS-CoV-2, Betacoronavirus, Biological Products, COVID-19, Coronavirus Infections, Humans, Immunosuppressive Agents, Italy, Pandemics, Pneumonia, Viral, Receptors, Interleukin-6, Respiration Disorders, Rheumatic Diseases, Risk Factors, SARS-CoV-2",
author = "Stefano Alivernini and Luca Petricca and Simone Perniola and Fedele, {Anna Laura} and Gigante, {Maria Rita} and Annunziata Capacci and Annamaria Paglionico and Valentina Varriano and {De Lorenzis}, Enrico and Lucia Lanzo and Fabrizio Melpignano and Pietro Rubortone and Giacomo Tanti and Carlo Tur and Dario Bruno and Laura Gigante and Gerlando Natalello and Lucrezia Verardi and {Di Mario}, Clara and Barbara Tolusso and Luisa Mirone and Lizzio, {Marco Maria} and Angelo Zoli and Giusy Peluso and Bosello, {Silvia Laura} and Elisa Gremese and Elisa Gremese",
year = "2020",
doi = "10.1093/rheumatology/keaa388",
language = "English",
volume = "59",
pages = "2644--2646",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford : Oxford University Press, 1999-",
}